Literature DB >> 15143335

Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.

Yoshiki Mikami1, Takako Kiyokawa, Sakae Hata, Keiichi Fujiwara, Takuya Moriya, Hironobu Sasano, Toshiaki Manabe, Jun-Ichi Akahira, Kiyoshi Ito, Toru Tase, Nobuo Yaegashi, Ikuro Sato, Hiroo Tateno, Hiroshi Naganuma.   

Abstract

Gastrointestinal phenotype in cervical adenocarcinomas was examined by immunohistochemistry and correlated with morphologic features. Antibody panels included anti-MUC2, MUC6, CD10, chromogranin A (CGA) and HIK1083. In addition, expression of p16INK4, a cyclin-dependent kinase inhibitor which is expressed in a variety of high-risk HPV-related conditions, was studied. A total of 94 invasive adenocarcinomas including 20 minimal deviation adenocarcinomas (MDAs) and 72 adenocarcinomas in situ (AIS) were examined. MDAs were most frequently positive for HIK1083 and/or MUC6, two representative gastric markers, with a rate of 95%, followed by intestinal-type adenocarcinomas (IAs) with a rate of 85% whereas only 27% of 56 usual endocervical-type adenocarcinomas (UEAs) were positive. MUC2, a goblet cell marker, was positive in 85% and 25% of IAs and MDAs, respectively, while in only 14% of UEAs. CD10 was positive in 15% of IAs, indicating incomplete intestinal differentiation without a brush border in most of the cases. CGA-positive cells were frequently seen in MDAs and IAs with rates of 60% and 62%, respectively. Nuclear and cytoplasmic p16INK4 positivity was identified in 93% of UEAs, whereas 30% of MDAs were positive for p16INK4. Results in AISs were comparable to their invasive counterparts, but morphologically usual-type AISs identified in eight cases of MDA were frequently positive for HIK1083 (75%) and MUC6 (63%), and p16INK4. Of note was the existence of lobular endocervical glandular hyperplasia (LEGH) with atypical features including cytologic abnormalities, and/or papillary projection, which were identified in this study in pure form (n=3) or in association with MDAs (n=6), but not in cases of other types of adenocarcinomas. These observations indicate that gastrointestinal phenotype is frequently expressed in MDAs and IAs, and there seems to be a possible link between MDA, and LEGH and morphologically usual-type AIS with gastric immunophenotype in histogenesis. Frequent absence of p16INK4 expression in MDAs suggests a possibility that high-risk HPV does not play a crucial role in development of MDAs, in contrast to the majority of endocervical adenocarcinomas. p16INK4 immunohistochemistry appears to be a promising diagnostic tool, but pathologists should be aware of frequent negative staining in MDAs, which can be a source of erroneous diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143335     DOI: 10.1038/modpathol.3800148

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  43 in total

1.  A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.

Authors:  Christina S Kong; Andrew H Beck; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

2.  Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.

Authors:  Yevgeniy S Karamurzin; Takako Kiyokawa; Vinita Parkash; Anjali R Jotwani; Prusha Patel; Malcolm C Pike; Robert A Soslow; Kay J Park
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

3.  Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type.

Authors:  Kazuhiro Yamanoi; Keiko Ishii; Michihiko Tsukamoto; Shiho Asaka; Jun Nakayama
Journal:  Virchows Arch       Date:  2018-05-29       Impact factor: 4.064

4.  New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.

Authors:  Andres A Roma; Toni-Ann Mistretta; Andrea Diaz De Vivar; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Norihiro Teramoto; Rouba Ali-Fehmi; Denise Barbuto; Joanne K L Rutgers; Elvio G Silva
Journal:  Gynecol Oncol       Date:  2016-04       Impact factor: 5.482

5.  Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.

Authors:  Eunhyang Park; Sang Wun Kim; Sunghoon Kim; Hyun-Soo Kim; Jung-Yun Lee; Young Tae Kim; Nam Hoon Cho
Journal:  Mod Pathol       Date:  2020-07-08       Impact factor: 7.842

6.  Fallopian Tube Mucosal Involvement in Cervical Gastric-type Adenocarcinomas: Report of a Series With Discussion of the Distinction From Synchronous In Situ Tubal Lesions.

Authors:  Simon Rajendran; Yaser Hussein; Kay J Park; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

7.  Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.

Authors:  Shiho Asaka; Tomoyuki Nakajima; Kaori Kugo; Risako Kashiwagi; Nozomi Yazaki; Tsutomu Miyamoto; Takeshi Uehara; Hiroyoshi Ota
Journal:  Virchows Arch       Date:  2020-01-13       Impact factor: 4.064

8.  Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens.

Authors:  Gulisa Turashvili; Elizabeth G Morency; Mihaela Kracun; Deborah F DeLair; Sarah Chiang; Robert A Soslow; Kay J Park; Rajmohan Murali
Journal:  Int J Gynecol Pathol       Date:  2019-05       Impact factor: 2.762

9.  Gastric-type mucinous adenocarcinoma of the uterine cervix with neoadjuvant therapy mimicking clear cell carcinoma.

Authors:  Yifen Zhang; Li Liang; Elizabeth D Euscher; Jinsong Liu; Preetha Ramalingam
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Clonal status and clinicopathological observation of cervical minimal deviation adenocarcinoma.

Authors:  Li Gong; Wen-Dong Zhang; Xiao-Yan Liu; Xiu-Juan Han; Li Yao; Shao-Jun Zhu; Miao Lan; Yan-Hong Li; Wei Zhang
Journal:  Diagn Pathol       Date:  2010-04-24       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.